Cyfuse Biomedical KK Sustainability Reports
Cyfuse Biomedical K.K. is a regenerative medicine company that develops and commercializes advanced 3D tissue-engineering products. It leverages its proprietary scaffold-free bio-3D printing technology to manufacture cell-based products, biomedical devices, and drug screening models.
Sector: Manufacturing
Country: Japan
Exchange: Tokyo Stock Exchange
FIGI: BBG0087CNLX0
1 reports from 2025 to 2025
Company Profile
Cyfuse Biomedical K.K. is a regenerative medicine company that develops and commercializes advanced 3D tissue-engineering products. It leverages its proprietary scaffold-free bio-3D printing technology to manufacture cell-based products, biomedical devices, and drug screening models.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
